Plasma Proteomics In Chronic Myeloid Leukemia Patients Before And After Initiation Of Tyrosine Kinase Inhibitor Therapy Reveals Induced Th1 Immunity And Loss Of Angiogenic Stimuli

Stina Söderlund,Lisa Christiansson,Inger Persson,Henrik Hjorth-Hansen,J. Richter,Bengt Simonsson,Satu Mustjoki,Ulla Olsson-Strömberg,Angelica Loskog

Plasma Proteomics In Chronic Myeloid Leukemia Patients Before And After Initiation Of Tyrosine Kinase Inhibitor Therapy Reveals Induced Th1 Immunity And Loss Of Angiogenic Stimuli

2016

Stina Söderlund
Lisa Christiansson
Inger Persson
Henrik Hjorth-Hansen
J. Richter
Bengt Simonsson
Satu Mustjoki
Ulla Olsson-Strömberg
Angelica Loskog

Plasma Proteomics In Chronic Myeloid Leukemia Patients Before And After Initiation Of Tyrosine Kinase Inhibitor Therapy Reveals Induced Th1 Immunity And Loss Of Angiogenic Stimuli

Keywords:

Immunology
Immunity
Hematology
Myeloid leukemia
Stimulus (physiology)
Tyrosine-kinase inhibitor
Medicine
Internal medicine
Proteomics
th1 immunity
plasma proteomics
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations